Evidence map›Paper›PMID 32051581›Full record

ArticleNature biomedical engineering2020

Author Correction: On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology.

David B Chou, Viktoras Frismantas, Yuka Milton, Rhiannon David, Petar Pop-Damkov, Douglas Ferguson, Alexander MacDonald, Özge Vargel Bölükbaşı, Cailin E Joyce, Liliana S Moreira Teixeira and 19 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature biomedical engineering, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Organoids and tissue/organ chips.Stem cell research & therapy · 2024
    Article
  2. Article
  3. 3D cancer models: One step closer toFrontiers in immunology · 2023
    Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors.

David B ChouWyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.ORCID http://orcid.org/0000-0002-1659-9308
Viktoras FrismantasWyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.
Yuka MiltonWyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.
Rhiannon DavidClinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Petar Pop-DamkovDMPK, Oncology R&D, AstraZeneca, Boston, MA, USA.
Douglas FergusonDMPK, Oncology R&D, AstraZeneca, Boston, MA, USA.
Alexander MacDonaldClinical and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, Pharmaceutical Sciences, R&D, AstraZeneca, Cambridge, UK.
Özge Vargel BölükbaşıDana Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.ORCID http://orcid.org/0000-0003-4013-6343
Cailin E JoyceDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.
Liliana S Moreira TeixeiraWyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.ORCID http://orcid.org/0000-0001-5039-8369
Arianna RechWyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.
Amanda JiangVascular Biology Program and Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
Elizabeth CalamariWyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.
Sasan Jalili-FiroozinezhadWyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.ORCID http://orcid.org/0000-0002-5004-893X
Brooke A FurlongWyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.
Lucy R O'SullivanWyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.ORCID http://orcid.org/0000-0002-9641-7315
Carlos F NgWyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.
Youngjae ChoeWyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.
Susan MarquezWyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.ORCID http://orcid.org/0000-0003-1183-8522
Kasiani C MyersDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Olga K WeinbergDepartment of Pathology, Boston Children's Hospital, Boston, MA, USA.
Robert P HasserjianDepartment of Pathology, Massachusetts General Hospital, Boston, MA, USA.
Richard NovakWyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.
Oren LevyWyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.
Rachelle Prantil-BaunWyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.
Carl D NovinaDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.
Akiko ShimamuraDana Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
Lorna EwartClinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Donald E IngberWyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA. don.ingber@wyss.harvard.edu.ORCID http://orcid.org/0000-0002-4319-6520

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID32051581

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.